Efficacy Analysis of Misoprostol Tablets for Painless Abortion

Advances in Obstetrics and Gynecology Research Pub Date : 2023-09-26 DOI:10.26689/aogr.v1i2.5376

Minchao Chen

{"title":"Efficacy Analysis of Misoprostol Tablets for Painless Abortion","authors":"Minchao Chen","doi":"10.26689/aogr.v1i2.5376","DOIUrl":null,"url":null,"abstract":"Objective: To analyze the application value of misoprostol tablets in painless abortion. Methods: 40 patients who received painless abortion from January 2022 to August 2023 were randomly divided into two groups; those who received misoprostol tablets before the operation were included in group A, and those who did not use misoprostol tablets before the operation were included in group B. Differences in cervical laxity, cervical dilatation time, uterine aspiration time, surgical blood loss, complications, and satisfaction were recorded. Results: The excellent and good rate of cervical dilation in group A was higher than that in group B (P < 0.05); the dilatation time, uterine suction time, surgical blood loss, and other indicators in group A were better than those in group B (P < 0.05); the complication rate after abortion in group A was lower than that of group B (P < 0.05); satisfaction rate in group A was higher than that of group B (P < 0.05). Conclusion: Oral administration of misoprostol tablets before painless abortion can relax the cervix, shorten the dilation time of the cervix, reduce intraoperative bleeding, and have higher patient satisfaction.","PeriodicalId":269611,"journal":{"name":"Advances in Obstetrics and Gynecology Research","volume":"51 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Obstetrics and Gynecology Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26689/aogr.v1i2.5376","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To analyze the application value of misoprostol tablets in painless abortion. Methods: 40 patients who received painless abortion from January 2022 to August 2023 were randomly divided into two groups; those who received misoprostol tablets before the operation were included in group A, and those who did not use misoprostol tablets before the operation were included in group B. Differences in cervical laxity, cervical dilatation time, uterine aspiration time, surgical blood loss, complications, and satisfaction were recorded. Results: The excellent and good rate of cervical dilation in group A was higher than that in group B (P < 0.05); the dilatation time, uterine suction time, surgical blood loss, and other indicators in group A were better than those in group B (P < 0.05); the complication rate after abortion in group A was lower than that of group B (P < 0.05); satisfaction rate in group A was higher than that of group B (P < 0.05). Conclusion: Oral administration of misoprostol tablets before painless abortion can relax the cervix, shorten the dilation time of the cervix, reduce intraoperative bleeding, and have higher patient satisfaction.

查看原文本刊更多论文

米索前列醇片用于无痛人流的疗效分析

目的:分析米索前列醇片在无痛人流中的应用价值。方法:选取2022年1月~ 2023年8月行无痛人流手术的患者40例，随机分为两组;术前服用米索前列醇片者为A组，术前未服用米索前列醇片者为b组。记录两组患者宫颈松弛度、宫颈扩张时间、子宫抽吸时间、手术出血量、并发症及满意度的差异。结果:A组宫颈扩张优良率明显高于B组(P <0.05);A组扩张时间、子宫吸引时间、手术出血量等指标均优于B组(P <0.05);A组流产后并发症发生率低于B组(P <0.05);A组满意率高于B组(P <0.05)。结论:无痛人流前口服米索前列醇片可使宫颈松弛，缩短宫颈扩张时间，减少术中出血，患者满意度较高。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Advances in Obstetrics and Gynecology Research

自引率

0.00%

发文量